Based on the critical role of CXCL8 in the metabolic remodelling of methionine in gliomas, we further used transcriptome sequencing to explore the gene expression changes involved in blocking the CXCL8–CXCR2 signaling axis in methionine-restricted tolerant cells[17]. The gene discussed is CXCR2; the disease is central nervous system cancer.